Related Experiment Video
Updated: May 6, 2026

ACT1-CUP1 Assays Determine the Substrate-Specific Sensitivities of Spliceosomal Mutants in Budding Yeast
Published on: June 30, 2022
Intron retention in the alternatively spliced region of RON results from weak 3' splice site recognition
Lindsay D Smith1, Christian M Lucas, Ian C Eperon
1Department of Biochemistry, University of Leicester, Leicester, United Kingdom.
Abstract:
The RON gene encodes a tyrosine kinase receptor for macrophage-stimulating protein. A constitutively active isoform that arises by skipping of exon 11 is expressed in carcinomas and contributes to an invasive phenotype. However, a high proportion of the mRNA expressed from the endogenous gene, or from transfected minigenes, appears to retain introns 10 and 11. It is not known whether this represents specific repression or the presence of weak splicing signals. We have used chimeric pre-mRNAs spliced in vitro to investigate the reason for intron retention. A systematic test showed that, surprisingly, the exon sequences known to modulate exon 11 skipping were not limiting, but the 3' splice site regions adjacent to exons 11 and 12 were too weak to support splicing when inserted into a globin intron. UV-crosslinking experiments showed binding of hnRNP F/H just 5' of these regions, but the hnRNP F/H target sequences did not mediate inhibition. Instead, the failure of splicing is linked to weak binding of U2AF65, and spliceosome assembly stalls prior to formation of any of the ATP-dependent complexes. We discuss mechanisms by which U2AF65 binding is facilitated in vivo.
Insights
Researchers investigated why the RON gene retains introns, finding weak splice sites, not exon sequences, cause this. This impacts cancer cell invasion by affecting splicing regulation.
Area of Science:
- Molecular Biology
- Genetics
- Cancer Research
Background:
- The RON gene encodes a tyrosine kinase receptor involved in cell signaling.
- A specific RON isoform, lacking exon 11, is linked to carcinoma invasiveness.
- Intron retention in RON mRNA is observed but its cause is unclear.
Purpose of the Study:
- To investigate the molecular mechanisms underlying intron 10 and 11 retention in RON mRNA.
- To determine if exon sequences or splice site strength are responsible for intron retention.
Main Methods:
- In vitro splicing assays using chimeric pre-mRNAs.
- Systematic testing of exon and splice site sequences.
- UV-crosslinking to identify protein binding factors.
- Analysis of spliceosome assembly intermediates.
Main Results:
- Weak 3' splice site regions adjacent to exons 11 and 12 were identified as the cause of intron retention.
- Exon sequences modulating exon 11 skipping were not limiting.
- hnRNP F/H binding occurred 5' of weak splice sites but did not inhibit splicing.
- Failure of splicing was linked to weak binding of U2AF65, stalling spliceosome assembly.
Conclusions:
- Weak 3' splice sites and impaired U2AF65 binding are the primary drivers of intron retention in RON mRNA.
- This splicing defect may contribute to the invasive phenotype observed in carcinomas.
- Further research is needed to understand in vivo mechanisms facilitating U2AF65 binding.
Related Concept Videos
RNA Splicing
RNA Splicing
Alternative RNA Splicing
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
Alternative RNA Splicing
Pre-mRNA Processing: RNA Splicing
Non-LTR Retrotransposons

